SEELOS THERAPEUTICS, INC. Quarterly Operating Lease, Liability in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Seelos Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2021 to Q2 2024.
  • Seelos Therapeutics, Inc. Operating Lease, Liability for the quarter ending June 30, 2024 was $47K, a 2.17% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $47K +$1K +2.17% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $62K +$2K +3.33% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $15K -$58K -79.5% Dec 31, 2023 10-K 2024-03-06
Q3 2023 $30K +$30K Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $46K +$33K +254% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $60K +$34K +131% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $73K +$35K +92.1% Dec 31, 2022 10-K 2023-03-10
Q3 2022 $0 -$51K -100% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $13K -$50K -79.4% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $26K -$48K -64.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $38K Dec 31, 2021 10-K 2022-03-04
Q3 2021 $51K Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $63K Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $74K Mar 31, 2021 10-Q 2021-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.